Short-Term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin

    December 2013 in “ European journal of endocrinology ”
    Mojca Jensterle Sever, Tomaz Kocjan, Marija Pfeifer … Andrej Janez
    Studysummary This study found that combining liraglutide with metformin led to greater weight loss and waist circumference reduction than either treatment alone in obese women with PCOS resistant to metformin monotherapy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eje.bioscientifica.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Reconsideration of Guidelines for Metformin Use in Ovulation Induction for PCOS by ESHRE and ASRM Hormones · 2013
    2. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009
    3. Evidence-Based and Potential Benefits of Metformin in Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008